Allergy and Immunology Credentialing: Requirements for Allergy, Asthma, and Immune Specialists

Allergy and immunology is a dual-specialty field recognized by both the American Board of Internal Medicine and the American Board of Pediatrics, reflecting the fact that allergists and immunologists treat patients across the full age spectrum — from children with food allergies and asthma to adults with primary immunodeficiency disorders and chronic urticaria. This breadth of patient population combined with a distinctive procedural practice centered on allergen skin testing and immunotherapy administration makes allergy and immunology credentialing unique among medical subspecialties.

The Allergy and Immunology Practice Environment

Allergists and immunologists practice predominantly in outpatient settings, with a relatively limited inpatient consultation component compared to many other internal medicine subspecialties. Most practices are office-based and involve a high volume of diagnostic procedures and in-office allergen immunotherapy administration. Hospital privileges are maintained for inpatient consultation on anaphylaxis, severe asthma, drug hypersensitivity evaluations, and primary immunodeficiency management.

The in-office allergen immunotherapy model creates specific credentialing and billing considerations. Immunotherapy requires both physician oversight and proper enrollment with commercial payers for the preparation and administration of allergen extracts — a billing model distinct from standard office visit or procedure billing that must be established correctly during payer enrollment.

Core Documentation Requirements for Allergists and Immunologists

A complete credentials file for an allergist-immunologist includes:

• Medical Education and Residency: Verification of medical school graduation and completion of an accredited residency in internal medicine or pediatrics. Both pathways lead to allergy and immunology fellowship eligibility.
• Fellowship Training: A two-year ACGME-accredited fellowship in Allergy and Immunology covering allergic disease, clinical immunology, asthma, food allergy, drug hypersensitivity, and primary immunodeficiency. Fellowship completion letters from program directors are required.
• Board Certification: The American Board of Allergy and Immunology (ABAI) offers certification jointly administered by ABIM and ABP. Diplomates must pass a written examination following fellowship completion. Maintenance of certification requires ongoing continuing medical education and periodic recertification.
• State Medical Licensure: All current and historical state licenses must be verified and fully disclosed including any disciplinary actions.
• DEA Registration: Allergists prescribing epinephrine auto-injectors, systemic corticosteroids, and certain biologics must maintain active DEA registration. While most allergy medications are non-controlled, DEA registration is standard practice.
• Malpractice Insurance History: A comprehensive five-to-ten year malpractice history covering all carriers, policy limits, and any claims or settlements.

Procedural Privileges in Allergy and Immunology

While allergy and immunology is primarily an outpatient specialty, several procedures require formal privilege documentation:

Allergen Skin Testing: Percutaneous prick testing and intradermal testing are the foundational diagnostic procedures of allergy practice. Although typically performed in office settings without formal hospital privilege requirements, some hospital systems and academic medical centers include these in their privilege delineation for allergy consultants.

Subcutaneous Allergen Immunotherapy Administration: The preparation and administration of allergen immunotherapy injections requires documented training and protocols. Practices must maintain emergency protocols for anaphylaxis management, as systemic reactions to immunotherapy occur and require immediate intervention.

Sublingual Immunotherapy (SLIT): Increasingly prescribed for environmental allergen desensitization and food allergy management, sublingual immunotherapy requires specific patient counseling and monitoring protocols documented in the practice's procedures.

Oral Food Challenges: Standardized food challenge procedures for food allergy diagnosis require documented training and the availability of emergency anaphylaxis management resources. Hospital-based food challenge programs require formal privilege documentation.

Biologic Administration: Allergists administering subcutaneous biologic injections such as dupilumab, benralizumab, or omalizumab in-office must ensure proper payer enrollment for the administration component of these services.

Spirometry and Pulmonary Function Testing: Allergists managing asthma frequently perform and interpret spirometry and pulmonary function tests in their offices. Hospital privileges for PFT interpretation may be required in certain settings.

Payer Enrollment for Allergists and Immunologists

Commercial payer enrollment for allergy and immunology specialists uses CAQH ProView as the primary data repository. The specialty taxonomy code for Allergy and Immunology is 207K00000X, with a subspecialty code for Clinical and Laboratory Immunology available for immunologists with that additional certification.

A critical payer enrollment consideration unique to allergy practices is the enrollment for allergen immunotherapy services. Commercial payers require separate enrollment and may have specific requirements for immunotherapy extract preparation, administration, and supervision billing. Allergists who prepare and administer immunotherapy must ensure that their practice is enrolled to bill both the professional component and the technical component of immunotherapy services.

Medicare enrollment through PECOS must reflect the correct allergy and immunology taxonomy. Medicare coverage for subcutaneous allergen immunotherapy is well-established, making timely enrollment essential for practices serving older patients with chronic allergic rhinitis and asthma.

Biologics for Allergy and Asthma: Enrollment Considerations

The emergence of biologic therapies for asthma, chronic rhinosinusitis, and atopic dermatitis has created important payer enrollment considerations for allergists. Biologics such as dupilumab, omalizumab, mepolizumab, and benralizumab are high-cost agents that require prior authorization from virtually all payers. Allergists who administer biologics in-office must ensure:

• Proper payer enrollment for both professional services and drug administration
• Familiarity with each payer's prior authorization requirements and step therapy policies
• Accurate buy-and-bill or specialty pharmacy billing depending on payer contract terms

Pediatric Allergy Credentialing Considerations

Allergists who trained through a pediatrics residency and treat primarily pediatric patients should ensure their credentialing reflects their pediatric training background. Some hospital systems with dedicated children's hospitals credential allergists through pediatric medical staff processes separate from adult medicine credentialing.

Managing Re-Credentialing and Quality Metrics

Re-credentialing for allergists and immunologists typically occurs every two years at hospitals and three years with most commercial payer networks. Practices that maintain current CAQH attestation, organized credentialing files, and proactive renewal tracking protect uninterrupted access to all payer networks and hospital consultation privileges. Partnering with a professional credentialing service experienced in allergy practice-specific enrollment ensures that the immunotherapy billing model and biologic administration services are properly supported from day one.